Federal Agencies Launch Joint Inquiry Into Private Investment In Health Care

DOJ, FTC, and HHS jointly announced the launching of a cross-government public inquiry into increasing private equity and corporate involvement in health care, the latest announcement in a string of public statements from the federal government on the topic.

On March 5, 2024, the Department of Justice (“DOJ”), Federal Trade Commission (“FTC”), and Department of Health and Human Services (“HHS”) jointly launched a “cross-government public inquiry” into increasing private equity and corporate involvement in health care. As […]

By | March 22nd, 2024 ||

Private Equity In Healthcare: Increased Scrutiny From FTC, DOJ, And HHS

On March 5, 2024, the Federal Trade Commission (“FTC”), the Department of Justice (“DOJ”) Antitrust Division, and Department of Health and Human Services (“HHS”) announced that they are launching a “cross-government public inquiry into private equity and other corporations’ increasing control over health care.” This effort is another step by regulators in their increased scrutiny of private equity. The inquiry seeks to understand how private equity transactions in the healthcare field affect consolidation, as well as […]

By | March 20th, 2024 ||

New Mexico’s Health Care Consolidation Oversight Act: An Overview

On March 1, 2024, New Mexico joined a growing number of states in enacting legislation that increases oversight of certain health care transactions. Senate Bill 15 (S.B. 15), which adds a new section to the New Mexico Insurance Code (the Code) titled the “Health Care Consolidation Oversight Act” (the Act), takes effect on May 1, 2024.
Overview of the Act
The Act gives New Mexico’s Office of Superintendent of Insurance (the Office) the power to review and […]

By | March 18th, 2024 ||